Brian R. Ott

179 papers receiving 6.4k citations

Brian R. Ott's Hit Papers

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial 2017 · 481 citations
4810+3+6Years since publication100200300400

Peers

Brian R. Ott
Comparison fields: 5 of 150
  • Physical Therapy, Sports Therapy and Rehabilitation 1.4k
  • Psychiatry and Mental health 2.0k
  • Transportation 578
  • Safety, Risk, Reliability and Quality 338
  • Neurology 287
Replace Holly Tuokko with:
Holly Tuokko Canada
Mark Rapoport Canada
Catherine M. Roe United States
Chengjie Xiong United States
Richard Dubinsky United States
Brenna Cholerton United States
Colette Fabrigoule France
Eric B. Larson United States
B. Lynn Beattie Canada
Dan Foley United States
Brian R. Ott relative to Holly Tuokko Canada Holly Tuokko's profile →
Citations per field
00.5×4.9×
Holly Tuokko · 1×
Citations per year

Countries citing papers authored by Brian R. Ott

Since Specialization
Citations

This map shows the geographic impact of Brian R. Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian R. Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian R. Ott more than expected).

Fields of papers citing papers by Brian R. Ott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian R. Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian R. Ott. The network helps show where Brian R. Ott may publish in the future.

Co-authors

The 25 scholars most cited alongside Brian R. Ott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Brian R. Ott Line = papers co-authored together Brian R. Ott links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 183 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial
Hit paper breakdown →
2017481
2
Cognitive Function in a Randomized Trial of Evolocumab
Hit paper breakdown →
2017339
3 2006239
4 2004202
5 1996177
6 2015164
7 2003151
8 2003149
9 2010148
10
Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes.
1995127
11 2005126
12 2008120
13 1996114
14 2002105
15 2004104
16 199295
17 199693
18 200493
19 201086
20 201184

About Brian R. Ott

Brian R. Ott is a scholar working on Psychiatry and Mental health, Physical Therapy, Sports Therapy and Rehabilitation, Transportation, Cognitive Neuroscience and Physiology, having authored 183 papers that have together received 6.7k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (76 papers), Older Adults Driving Studies (48 papers), Urban Transport and Accessibility (18 papers), Alzheimer's disease research and treatments (10 papers), Health Systems, Economic Evaluations, Quality of Life (9 papers), Neurological Disease Mechanisms and Treatments (8 papers), Cholinesterase and Neurodegenerative Diseases (6 papers) and Spatial Neglect and Hemispheric Dysfunction (6 papers). The work is most often cited by research in Physical Therapy, Sports Therapy and Rehabilitation (1.4k citations), Psychiatry and Mental health (2.0k citations), Transportation (578 citations), Safety, Risk, Reliability and Quality (338 citations) and Neurology (287 citations). Brian R. Ott has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Rebecca E. Ready, Janet Grace, William C. Heindel, David B. Carr, Lori A. Daiello, George D. Papandonatos, Barry S. Fogel, Jennifer Davis, Elena K. Festa and Geoffrey Tremont. Their work appears in journals such as Alzheimer s & Dementia, Journal of the American Geriatrics Society, Journal of Geriatric Psychiatry and Neurology, Journal of Alzheimer s Disease and Alzheimer Disease & Associated Disorders.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact